HopeStage
Back to all studies
TerminatedNCT00308776

Cholecystokinin for Reducing Binge Eating in People With Eating disorders

Placebo comparisonAges 18–55United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

The protocol includes: Completing questionnaires.

Listed locations
New YorkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateOctober 2003
Recruitment status
Terminated
Enrollment listed in the registry
6
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Procedure
Intervention type
Procedure
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT00308776
Official title
Show the full official title

Effect of Cholecystokinin on Binge Eating in Bulimia Nervosa

Recruitment & locations

Terminated

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What will I need to do?

You will complete questionnaires.

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies